Epidermolysis Bullosa Simplex: Clinical Trials

2 trials for Epidermolysis Bullosa Simplex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1
Phase 32Active not recruiting 1, Completed 1

Follow Epidermolysis Bullosa Simplex: new trials by email Literature Review of Epidermolysis Bullosa Simplex trials Research Report on Epidermolysis Bullosa Simplex

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
AC-203, Vehicle - Generalized Epidermolysis Bullosa Simplex
Phase 2 / Phase 3Active not recruitingTWi Biotechnology, Inc.802024-04-042026-07-09
Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex
Botulinic toxin, Placebo - Epidermolysis Bullosa Simplex
Phase 2 / Phase 3CompletedUniversity Hospital, Toulouse182018-06-142026-09-21

Narrower conditions

Blister (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Epidermolysis Bullosa (2)  ·  Genetic Diseases, Inborn (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin Diseases, Vesiculobullous (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Drugs, Investigational (1)  ·  abobotulinumtoxinA (1)  ·  diacerein (1)

Sponsors

TWi Biotechnology, Inc. (1)  ·  University Hospital, Toulouse (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  Greece (1)  ·  India (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Philippines (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Juliette Mazereeuw-Hautier, MD (1)

NIH funding

2017 (1)